124 related articles for article (PubMed ID: 38158813)
1. AIDS-related gastrointestinal cytomegalovirus end-organ disease: A retrospective cohort study at a tertiary center in São Paulo, Brazil.
Reis Schneider GA; Bogoni G; Castanheira NF; Lucas Júnior RM; Vidal JE
Int J STD AIDS; 2024 Apr; 35(5):365-373. PubMed ID: 38158813
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related cytomegalovirus encephalitis in the late ART era: A retrospective cohort study at a referral center in Brazil.
Lucas Júnior RM; Bogoni G; Reis Schneider GA; Castanheira de Souza NF; Carvalho MK; Vidal JE
Int J STD AIDS; 2023 Mar; 34(4):229-235. PubMed ID: 36068969
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus retinitis in hospitalized people living with HIV in the late antiretroviral therapy era in São Paulo, Brazil.
Bogoni G; Lucas Júnior RM; Reis Schneider GA; Castanheira de Souza NF; Carvalho MK; Marcusso RM; Vidal JE
Int J STD AIDS; 2023 Jan; 34(1):48-53. PubMed ID: 36259434
[TBL] [Abstract][Full Text] [Related]
4. Low frequency of cytomegalovirus (CMV) disease despite high prevalence of CMV viraemia in patients with advanced HIV infection: a clinical and immunological 48-week follow-up study.
Albasanz-Puig A; Suanzes P; Esperalba J; Fernández C; Sellarès-Nadal J; Torrella A; Planas B; Segura A; Burgos J; Ribera E; Cañas-Ruano E; García JN; Navarro J; Curran A; Len Ó; Falcó V
HIV Med; 2021 Sep; 22(8):682-689. PubMed ID: 33998115
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of quantitative plasma cytomegalovirus DNA PCR for cytomegalovirus end-organ diseases in patients with HIV-1 infection.
Mizushima D; Nishijima T; Yashiro S; Teruya K; Kikuchi Y; Katai N; Oka S; Gatanaga H
J Acquir Immune Defic Syndr; 2015 Feb; 68(2):140-6. PubMed ID: 25590268
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).
Erice A; Tierney C; Hirsch M; Caliendo AM; Weinberg A; Kendall MA; Polsky B;
Clin Infect Dis; 2003 Aug; 37(4):567-78. PubMed ID: 12905142
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of gastrointestinal manifestations among Cytomegalovirus end-organ disease in the combination antiretroviral era.
Caplan MR; Wilson EMP; Schechter M; Cai CW; Venner A; Bishop R; Adelsberger J; Higgins J; Roby G; Wang J; Sheikh V; Sereti I
J Virus Erad; 2021 Sep; 7(3):100052. PubMed ID: 34557308
[TBL] [Abstract][Full Text] [Related]
8. Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART era.
Mizushima D; Nishijima T; Gatanaga H; Tsukada K; Teruya K; Kikuchi Y; Oka S
PLoS One; 2013; 8(5):e65348. PubMed ID: 23724140
[TBL] [Abstract][Full Text] [Related]
9. Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.
Wohl DA; Kendall MA; Andersen J; Crumpacker C; Spector SA; Feinberg J; Alston-Smith B; Owens S; Chafey S; Marco M; Maxwell S; Lurain N; Jabs D; Benson C; Keiser P; Jacobson MA;
HIV Clin Trials; 2009; 10(3):143-52. PubMed ID: 19632953
[TBL] [Abstract][Full Text] [Related]
10. CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIV-infected patients in the HAART era.
Skiest DJ; Crosby C
J Clin Virol; 2003 Oct; 28(2):203-13. PubMed ID: 12957190
[TBL] [Abstract][Full Text] [Related]
11. Frequency of Cytomegalovirus Viral Load in Iranian Human Immunodeficiency Virus-1-Infected Patients with CD4+ Counts <100 Cells/mm3.
Jabbari MR; Soleimanjahi H; Shatizadeh Malekshahi S; Gholami M; Sadeghi L; Mohraz M
Intervirology; 2021; 64(3):135-139. PubMed ID: 33789308
[TBL] [Abstract][Full Text] [Related]
12. Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from India.
Chakraborty A; Mahapatra T; Mahapatra S; Ansari S; Siddhanta S; Banerjee S; Banerjee D; Sarkar RN; Guha SK; Chakraborty N
PLoS One; 2015; 10(2):e0117466. PubMed ID: 25679798
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the efficacy and safety of pre-emptive anti-cytomegalovirus (CMV) therapy in HIV-infected patients with CMV viraemia.
Mattioni S; Pavie J; Porcher R; Scieux C; Denis B; De Castro N; Simon F; Molina JM
Int J STD AIDS; 2015 Apr; 26(5):306-12. PubMed ID: 24845948
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.
Wohl DA; Zeng D; Stewart P; Glomb N; Alcorn T; Jones S; Handy J; Fiscus S; Weinberg A; Gowda D; van der Horst C
J Acquir Immune Defic Syndr; 2005 Apr; 38(5):538-44. PubMed ID: 15793363
[TBL] [Abstract][Full Text] [Related]
15. Neurologic cytomegalovirus complications in patients with AIDS: retrospective review of 13 cases and review of the literature.
Silva CA; Oliveira AC; Vilas-Boas L; Fink MC; Pannuti CS; Vidal JE
Rev Inst Med Trop Sao Paulo; 2010; 52(6):305-10. PubMed ID: 21225213
[TBL] [Abstract][Full Text] [Related]
16. Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34
Huang YT; Kim SJ; Lee YJ; Burack D; Nichols P; Maloy M; Perales MA; Giralt SA; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1759-1766. PubMed ID: 28668490
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS.
Weinberg A; Bosch R; Bennett K; Tovar-Salazar A; Benson CA; Collier AC; Zolopa A; Gulick RM; Wohl D; Polsky B; Erice A; Jacobson MA
J Acquir Immune Defic Syndr; 2014 May; 66(1):25-32. PubMed ID: 24378728
[TBL] [Abstract][Full Text] [Related]
18. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1.
Komanduri KV; Viswanathan MN; Wieder ED; Schmidt DK; Bredt BM; Jacobson MA; McCune JM
Nat Med; 1998 Aug; 4(8):953-6. PubMed ID: 9701250
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus Esophagitis in an Immunocompromised Patient.
Ali AA; Anasseri S; Abou-Ghaida J; Walker L; Barber T
Cureus; 2023 Sep; 15(9):e45634. PubMed ID: 37868477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
